Skip to main content
    Q

    Quanterix Corp (QTRX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.84
    -0.09 (-3.07%)

    Market Cap: $139.11M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(20/36)
    Avg Surprise
    +1.19%
    Streak
    3 Q

    Upcoming Estimates

    Reports Jan 6, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.41
    Range-$0.44 - -$0.37
    5 analysts
    Revenue Consensus
    $39.67M
    Range$37.63M - $41.79M
    5 analysts
    Reports May 4, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.48
    Range-$0.55 - -$0.40
    2 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current-$0.48
    Revenue Consensus
    $35.76M
    Range$34.00M - $37.20M
    3 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-2.39xFCF Yield-41.78%
    Profitability
    Profit Margin-75.00%Operating Margin-53.60%
    ROE-41.60%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio3.09xQuick Ratio2.22x
    Trading Statistics
    Beta1.02Avg Volume499.43K
    52-Week High$8.7752-Week Low$2.15

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 6.9% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 45.6, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$2.99
    SMA 20$2.94
    SMA 50$3.05
    SMA 200$3.65
    EMA 10$2.97
    EMA 20$2.99
    EMA 50$3.05
    EMA 200$3.68

    MACD

    Line: -0.03Signal: -0.03Hist: -0.00

    ADX

    ADX: 13.0+DI: 22.3-DI: 25.7

    Aroon & PSAR

    Aroon Up84.0
    Aroon Down28.0
    PSAR$3.52

    Bollinger Bands

    Upper Band$3.29
    Lower Band$2.60
    %B Position2356%(Upper)
    Band Width0.35

    RSI (14-Day)

    Neutral
    45.6

    Momentum Oscillators

    Stoch %K19.8
    Stoch %D29.6
    Williams %R-84.7
    ROC (10d)1.1%
    Momentum0.03
    CCI (20d)-63.2
    MFI (14d)56.3

    Volatility Measures

    ATR (14d)$0.26(9.1%)
    StdDev (20d)0.17
    Hist Vol95.5%(High)

    Volume Flow

    VWAP$2.83
    OBV-13.1M
    AD Line-1.9M
    CMF (20d)0.054

    Volume Metrics

    Avg Vol (20d)502.9K
    Vol Ratio1.2x
    VWMA (20d)$2.98

    Pivot Points

    R3$3.31
    R2$3.17
    R1$3.05
    Pivot Point$2.92
    S1$2.79
    S2$2.66
    S3$2.54

    Advanced Oscillators

    TSI-2.98
    Ultimate Osc48.1
    KST-35.50

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about QTRX

    Gov Obligations (TTM)
    $180,314
    Gov Obligations / Revenue
    0.1%
    Obligations YoY
    N/A
    Active Awards
    8
    New Awards (TTM)
    3
    Avg Remaining Term
    13.9 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    QTRX Valuation

    GNG's valuation label for QTRX is Undervalued.

    P/FCF
    -2.4x
    P/B
    0.6x
    All QTRX metrics

    QTRX Profitability: Margins, ROIC and FCF

    Quanterix (QTRX) has a gross margin of 41.7%, an operating margin of -53.6% and a net margin of -75.0%. It posts a -38.0% FCF margin.

    Gross margin
    41.7%
    Operating margin
    -53.6%
    Net margin
    -75.0%
    ROE
    -41.6%
    FCF margin
    -38.0%
    FCF yield
    -41.8%
    QTRX financial statements

    Quanterix Competitors

    The companies most similar to Quanterix (QTRX) include QuantumSi, MaxCyte and TriSalus Life Sciences.

    Sector: Healthcare

    Companies most similar to Quanterix

    QTRX Analyst Ratings

    Quanterix (QTRX) has a Hold consensus from 3 analysts: 0 Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell.

    Consensus
    Hold
    Analysts
    3
    Strong Buy
    0
    Buy
    0
    Hold
    3
    Sell
    0
    Strong Sell
    0
    QTRX stock forecast

    QTRX Bull Case vs Bear Case

    Bear case

    • QTRX has a -75.0% net profit margin.
    • QTRX beat EPS estimates in 37.5% of its last 8 reported quarters.
    • QTRX's quarterly revenue changed -13.1% year over year.

    QTRX Earnings: Beat Rate and Next Report

    Quanterix (QTRX) beat the EPS estimate in 3 of the last 8 quarters (37.5%). Its next report is expected on Jan 6, 2027.

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    6.1%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.41
    QTRX earnings history

    QTRX Earnings Date

    QTRX reports Jan 6, 2027. The date is estimated.

    QTRX Earnings Call

    The latest QTRX earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    See insider activity

    Updated Nov 9, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About QTRX

    When does QTRX report earnings?

    Quanterix Corp (QTRX) is expected to report earnings on Jan 6, 2027.

    Does QTRX pay dividends?

    Quanterix Corp (QTRX) does not currently pay a regular dividend.

    What is QTRX's market cap?

    Quanterix Corp (QTRX) has a market capitalization of $139.11M with a current stock price of $2.84.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.